Smartphone-based– tag –
-
Medtronic Enhances MiniMed 780G AID System with New CGM Sensors and Launches Screenless MiniMed Flex Pump
diaTribe.org USA Overview Medtronic has introduced two new continuous glucose monitor (CGM) sensors for its MiniMed 780G automated insulin delivery (AID) system in the U.S.: the 6-day Simplera Sync and the 15-day Instinct (based on Abbot... -
FDA Clears Dexcom’s Stelo, First Over-the-Counter CGM for Non-Insulin-Using Children Aged Two and Older
FDA USA Overview The U.S. FDA has approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged two and older who do not use insulin. This expansion significantly ... -
FDA Approves Finger-Prick Free Dexcom Stelo and Abbott Libre CGMs, Revolutionizing Metabolic Management for Non-Insulin Users
Mattioli 1885 / GoodRx USA Overview The FDA has approved continuous glucose monitoring (CGM) systems like Dexcom Stelo and Abbott's Lingo (and FreeStyle Libre series), eliminating the need for traditional finger-prick tests and marking a... -
Smartphone Digital Biomarkers Take Center Stage in Herantis Pharma’s Phase 2a Parkinson’s Trial
Biospace (Herantis Pharma press release) フィンランド Overview Herantis Pharma has finalized its HER-096 Phase 2a trial for Parkinson's disease, integrating Indivi's SynapTrack smartphone-based digital biomarker platform, following posit... -
Wearable Colorimetric Biosensor Utilizes Copper Coordination Polymer Nanozymes for Noninvasive, Real-time Monitoring of Ascorbic Acid in Sweat
Langmuir (ACS Publications) Unknown Overview A wearable colorimetric biosensor based on copper coordination polymer nanozymes (CPNs) has been developed for noninvasive, real-time monitoring of ascorbic acid (AA) in sweat. The sensor exhi... -
POCT Innovations and Rapid Diagnostics Combat Antimicrobial Resistance: Insights from DX Innovation Summit
DX Innovation Summit USA Overview The DX Innovation Summit addressed how advancements in sensor, microfluidic, and smartphone technologies are transforming Point-of-Care Testing (POCT) diagnostics, enabling faster and more accurate disea... -
FDA Clears Dexcom Stelo: First Over-the-Counter Continuous Glucose Monitor to Transform Non-Insulin-Dependent Diabetes Management
U.S. Food and Drug Administration (FDA) News Release USA Overview The U.S. FDA has cleared the Dexcom Stelo Glucose Biosensor System, the first over-the-counter (OTC) continuous glucose monitor (CGM) for individuals aged 18 and older not... -
Washington State University Unveils Minimally Invasive Wireless Microneedle Glucose Sensor for Smarter Diabetes Management
ICT&health Netherlands Overview Washington State University researchers have developed a new wearable biosensor to significantly enhance glucose monitoring for diabetes patients. This technology combines microneedles, advanced catalytic ... -
3D-Printed Hollow Microneedle Biosensor Achieves Wireless, Continuous Glucose Monitoring with Ultra-High Sensitivity
Analyst (RSC Publishing) UK Overview Researchers have developed a 3D-printed hollow microneedle-based electrochemical sensor capable of continuous, wireless glucose monitoring by extracting artificial interstitial fluid. Incorporating si... -
Smart Dressing Patch from KAIST Enables Real-Time Diagnosis and Continuous Management of Diabetic Ulcers
KAIST (韓国科学技術院) South Korea Overview KAIST researchers have developed a smart dressing patch for real-time diagnosis and continuous management of diabetic ulcers. Integrating photoelectric sensors, functional nanofibers, and NFC t...
